Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPharmacotherapy for the Obese Patient
Primary Care: Clinics in Office Practice, 06/15/09
Dickerson LM et al. - The long-term safety of many antiobesity pharmacologic regimens has not been adequately evaluated. If recommended and prescribed, pharmacologic agents should be an adjunct to a structured diet and exercise regimen. Unfortunately, weight gain after discontinuation of antiobesity agents is common. In addition, the effect of weight loss obtained through the use of pharmacotherapeutic agents on overall morbidity and mortality has not been established.
Related Articles
Obesity, intentional weight loss and physical disability in older adults
Obesity Reviews, 11/18/09
Relevance Score: 94%
Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09
Relevance Score: 94%
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Relevance Score: 94%
Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09
Relevance Score: 93%
Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09
Relevance Score: 93%
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatic steatosis in overweight/obese females: New screening method for those at risk
World Journal of Gastroenterology, 12/11/09
New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09
Obesity and cardiovascular disease: From pathophysiology to risk stratification
International Journal of Cardiology, 12/10/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
Clinical and Experimental Gastroenterology, 12/11/09
Chemoprevention in Barrett's Esophagus: Are We There Yet, Are We There Yet...
Clinical Gastroenterology and Hepatology , 12/11/09
Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV
World Journal of Gastroenterology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor